However, the study also determined that the rate of LDL degradation is lower in CLL cells than in B-cells from healthy individuals, and that LDLR activity was no different in CLL cells than in healthy B-cells [40]. The gene discussed is LDLR; the disease is B-cell chronic lymphocytic leukemia.